Centiva Capital’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
+50,000
New +$1.17M 0.01% 545
2024
Q4
Sell
-9,899
Closed -$238K 1677
2024
Q3
$238K Sell
9,899
-6,267
-39% -$143K ﹤0.01% 1722
2024
Q2
$322K Buy
+16,166
New +$315K 0.01% 1419
2022
Q1
Sell
-7,723
Closed -$268K 1611
2021
Q4
$268K Buy
7,723
+1,050
+16% +$33.9K 0.01% 934
2021
Q3
$207K Buy
+6,673
New +$226K 0.01% 912

Other funds holding AVNS

Centiva Capital's AVNS Position: Q2 2026 in Review

Centiva Capital opened a new position in Avanos Medical (AVNS) in Q2 2026: 50,000 shares worth $1.24M. The stake represents 0.01% of the portfolio and ranks #545 among its holdings. This is a return to the name: Centiva Capital previously reported a position in AVNS as recently as Q3 2024.

Centiva Capital first reported a position in AVNS in Q3 2021 and has held it in 5 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Centiva Capital held 50,000 shares of Avanos Medical worth $1.24M as of Q2 2026.
  • Avanos Medical was a new Centiva Capital position in Q2 2026.
  • Avanos Medical made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #545 holding.
  • Centiva Capital first reported a position in Avanos Medical in Q3 2021 and has held it in 5 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.